SU908373A1 - Method of introducing endocardial electrode - Google Patents
Method of introducing endocardial electrode Download PDFInfo
- Publication number
- SU908373A1 SU908373A1 SU802858453A SU2858453A SU908373A1 SU 908373 A1 SU908373 A1 SU 908373A1 SU 802858453 A SU802858453 A SU 802858453A SU 2858453 A SU2858453 A SU 2858453A SU 908373 A1 SU908373 A1 SU 908373A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- electrode
- endocardium
- contact
- vein
- contact head
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 210000003462 vein Anatomy 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 6
- 210000001174 endocardium Anatomy 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims 3
- 230000037431 insertion Effects 0.000 claims 3
- 238000002513 implantation Methods 0.000 claims 1
- 239000002904 solvent Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
(St) СПОСОБ ВВЕДЕНИЯ ЭНДОКАРДИАЛЬНОГО (St) METHOD FOR INTRODUCTION OF ENDOCARDIAL
II
Изобретение относитс к медицине.This invention relates to medicine.
Известен способ введени эндокардиального электрода путем введени электрода в вену шеи до соприкосновени с эндокардом под рентгенологическим контролем .There is a method of introducing an endocardial electrode by introducing an electrode into a vein of the neck before contact with the endocardium under x-ray control.
Однако эндокардиальиый электрод трудно и опасно вводить через узкие вены, особенно у детей, кроме того, катетер может вызвать повреждени стенок сердца и вены.However, the endocardial electrode is difficult and dangerous to insert through narrow veins, especially in children, and in addition, the catheter can cause damage to the walls of the heart and veins.
Цель изобретени - упрощение способа .The purpose of the invention is to simplify the method.
Эта цель достигаетс тем,что способ введени эндокардиального электрода осуществл ют путем введени электрода в вену шеи до соприкосновени с эндокардом под рентгенологическим контролем, контактную головку электрода с фиксирующими средствами перед введением покрывают смесью, состо щей из гепарина и пс лиглюкина в соотношении 1:2т8:9ЭЛЕКТРОДА .This goal is achieved by introducing the endocardial electrode by inserting the electrode into the vein of the neck before contact with the endocardium under X-ray control, the contact head of the electrode with fixing means is coated with a mixture consisting of heparin and ps liglucin in a 1: 2t8 ratio: 9 ELECTRODE.
Способ осуществл етс следующим образом.The method is carried out as follows.
Непосредственно перед операцией из веществ, относ щихс к кровозаменител м и раствор ющихс в крови без по бочных влений, и растворител готов т 1-2 г тестообразной смеси. Например , берут порошкообразный полиглюкин , а в качестве растворител гепарин в следующих весовых соотно10 -шени х, вес.:Immediately before the operation, 1-2 g of dough mixture is prepared from substances related to blood substitutes and dissolving in the blood without adverse effects, and the solvent. For example, powdered polyglucine is taken, and heparin is used as a solvent in the following weight ratios: 10-x, weight:
Полиглюкин80-90Poliglyukin80-90
Гепарин10-20Heparin10-20
и смешивают. Полученной тестообразной смесью покрывают контактную головку and mixed. The resulting pasty mixture covers the contact head
15 электрода с фиксирующими крючками. Затем слегка подогрева , высушивают покрывающую головку смесь до ее полного затвердени в течение 2-3 мин.15 electrodes with locking hooks. Then slightly heated, the coating mixture is dried up until it is completely hardened within 2-3 minutes.
Затем известным способом вскрывают Then, in a known manner, open
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU802858453A SU908373A1 (en) | 1980-01-11 | 1980-01-11 | Method of introducing endocardial electrode |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU802858453A SU908373A1 (en) | 1980-01-11 | 1980-01-11 | Method of introducing endocardial electrode |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU908373A1 true SU908373A1 (en) | 1982-02-28 |
Family
ID=20867401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU802858453A SU908373A1 (en) | 1980-01-11 | 1980-01-11 | Method of introducing endocardial electrode |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU908373A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4827940A (en) * | 1987-04-13 | 1989-05-09 | Cardiac Pacemakers, Inc. | Soluble covering for cardiac pacing electrode |
| US5658326A (en) * | 1995-09-12 | 1997-08-19 | Pacesetter Ab | Protective body for an implantable electrical conductor and an electrical conductor equipped with such an end protector |
| US5709710A (en) * | 1995-05-10 | 1998-01-20 | Armstrong; Randolph Kerry | Implantable cardioverter/defibrillator with adaptive shock coupling interval and method |
-
1980
- 1980-01-11 SU SU802858453A patent/SU908373A1/en active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4827940A (en) * | 1987-04-13 | 1989-05-09 | Cardiac Pacemakers, Inc. | Soluble covering for cardiac pacing electrode |
| US5709710A (en) * | 1995-05-10 | 1998-01-20 | Armstrong; Randolph Kerry | Implantable cardioverter/defibrillator with adaptive shock coupling interval and method |
| US5658326A (en) * | 1995-09-12 | 1997-08-19 | Pacesetter Ab | Protective body for an implantable electrical conductor and an electrical conductor equipped with such an end protector |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0161140B1 (en) | Rate scanning demand pacemaker and method for treatment of tachycardia | |
| Wellens et al. | Second degree block during reciprocal atrioventricular nodal tachycardia. | |
| Grillner et al. | Entrainment of the spinal pattern generators for swimming by mechano-sensitive elements in the lamprey spinal cord in vitro | |
| Fisher et al. | Termination of ventricular tachycardia with bursts of rapid ventricular pacing | |
| Aasted et al. | Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience | |
| US6129750A (en) | Fixation mechanism for a coronary venous pacing lead | |
| US5531783A (en) | Pacing lead with x-ray visible soluble covering and method of inserting same into a patient's heart | |
| Kottkamp et al. | Variants of Preexcitation—Specialized Atriofascicular Pathways, Nodofascicular Pathways, and Fasciculoventricuiar Pathways: Electrophysiologic Findings and Target Sites for Radiofrequency Catheter Ablation | |
| JPH0928814A (en) | Atrium rate determining and atrium tachycardia detecting method in dual chamber pacemaker | |
| Haft | Treatment of arrhythmias by intracardiac electrical stimulation | |
| EP0256462A2 (en) | Process for permanently shaping hair | |
| Eyzaguirre et al. | Experimental myotonia and repetitive phenomena: the veratrinic effects of 2, 4-dichlorphenoxyacetate (2, 4-D) in the rat | |
| SU908373A1 (en) | Method of introducing endocardial electrode | |
| Sun et al. | Action of externally applied ATP on rat reticulospinal vasomotor neurons | |
| Soloff et al. | The supernormal phase of ventricular excitation in man. Its bearing on the genesis of ventricular premature systoles, and a note on atrioventricular conduction | |
| Nosáľvá et al. | Antitussive activity of a rhamnogalacturonan isolated from the roots of Althaea officinalis L., var. Robusta | |
| Narula et al. | Accommodation of AV nodal conduction and fatigue phenomenon in the His-Purkinje system | |
| Galligan et al. | Effects of cholinergic blockade, adrenergic blockade and sympathetic denervation on gastrointestinal myoelectric activity in guinea pig. | |
| JPH09103495A (en) | Protector | |
| NL8006756A (en) | ATRIAL-VENTRICULAR ENDOCARDIAL CONDUCTOR. | |
| Brugada et al. | Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway | |
| Kus et al. | Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time | |
| Stewart et al. | THE LIBERATION OF EPINEPHRIN FROM THE ADRENAL GLANDS BY STIMULATION OF THE SPLANCHNIC NERVES AND BY MASSAGE: STUDIED BY MEANS OF THE DENERVATED EYE REACTION | |
| Della Bella et al. | Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing | |
| RU2123843C1 (en) | Composition for treatment of wounds of different etiology |